Badger Meter Reports First Quarter 2025 Financial Results

Badger Meter Reports First Quarter 2025 Financial Results

MILWAUKEE–(BUSINESS WIRE)–Badger Meter, Inc. (NYSE: BMI) today reported results for the first quarter ended March 31, 2025.

First Quarter 2025 Highlights

  • Total sales of $222.2 million, 13% higher than the prior year’s $196.3 million.
  • Operating earnings increased 35% year-over-year to $49.5 million, with operating profit margins expanding 360 basis points to 22.2% from 18.6%.
  • Diluted earnings per share (EPS) increased 31% to $1.30, up from $0.99 in the comparable prior year quarter.
  • Completed the acquisition of SmartCover on January 30, 2025.

“Steady customer demand and disciplined operating execution drove solid revenue growth and record margins in a strong start to 2025. Our ability to build upon record results reflects the underlying stability of our business model as favorable industry fundamentals drive the need for our innovative smart water solutions,” said Kenneth C. Bockhorst, Chairman, President and Chief Executive Officer. “Since closing the acquisition of SmartCover in late January, we’ve made swift progress in our integration efforts. We remain encouraged by the positive feedback received from customers on the addition of SmartCover’s sewer and lift-station monitoring capabilities to our BlueEdge® portfolio of tailorable water management solutions. I’d like to thank all of our dedicated employees for working together to deliver these solid results.”

First Quarter Operating Results

Utility water sales increased 16% year-over-year, including two months of the SmartCover acquisition. Excluding SmartCover, utility water sales increased 12%, the result of ongoing customer adoption across the suite of digital smart water solutions, led by increased mechanical and E-Series Ultrasonic meter, ORION® Cellular radio endpoint and BEACON® SaaS sales.

Sales of flow instrumentation products declined 5%, with modest growth in water-related markets offset by lower demand in the de-emphasized array of market applications. Notably, sales increased sequentially 7% from the fourth quarter of the prior year.

Operating earnings increased 35% year-over-year, with operating margins improving 360 basis points to a record 22.2% from the prior year’s 18.6%. Gross margin was 42.9%, up 360 basis points year-over-year from 39.3% in the comparable prior year quarter. The record gross margin percent was the result of especially favorable product and customer sales mix, as well as benefits from operational excellence initiatives. Tariff and related impacts in the first quarter of 2025 were de minimis.

Total Selling, Engineering and Administration (SEA) expenses increased $5.4 million, or 13% year-over-year, due primarily to the inclusion of SmartCover, including approximately $1.1 million of intangible asset amortization. Excluding the acquisition, SEA expenses increased $2.2 million or 5%. In total, SEA as a percent of sales remained flat at 20.7%.

The tax rate for the first quarter of 2025 was 24.4%, modestly above the prior year’s 23.5%. As a result of the above, as well as lower interest income resulting from the acquisition capital deployed, EPS was $1.30, up 31% compared to $0.99 in the comparable prior year period.

Outlook

Bockhorst continued, “Our first quarter results demonstrate the resilience and durability of our replacement-driven business amidst a volatile macroeconomic environment. As previously communicated, we will face difficult prior-year comparisons in the upcoming second quarter of 2025. Nevertheless, the attractive fundamentals of the water industry, and our ability to add value to customers with an innovative and reliable portfolio of solutions, support our average high-single-digit long-term revenue growth outlook.

We delivered record gross margins in the first quarter, benefiting from a notably favorable combination of product and customer sales mix. While this clearly demonstrates that the structural mix benefit of technology adoption within our business is real, given the evolving tariff picture and related uncertainty, we believe it is prudent to maintain our normalized gross margin range of 38-40% at this time. At present, we are confident in our ability to manage certain tariff-related cost challenges. Our history of strong operational execution, particularly in the management of our supply chain, manufacturing footprint, and value-based pricing strategy, underscores our proven ability to control what we can control in a turbulent economic environment.

The addition of SmartCover earlier this year emphasizes the growing extensibility and appeal of our BlueEdge suite of products and services. Our customers continue to feel the impact of extreme weather events, which makes SmartCover’s stormwater management offering a compelling part of our portfolio. Although still early in the integration, we’re on track for delivering anticipated sales and cost synergies. Importantly, our solid balance sheet gives us the financial flexibility to fund the capital allocation priorities supporting our long-term strategy, including value-added, disciplined acquisitions.

Bockhorst concluded, “We were proud to be named for the third consecutive year to Barron’s 2025 list of 100 Most Sustainable Companies. We carry a responsibility for protecting the world’s most precious resource. This gives our employees a sense of purpose, which powers our innovation engine, delivers solutions to our end markets, and generates steady long-term shareholder value.”

Conference Call and Webcast Information

Badger Meter management will hold a conference call to discuss the Company’s first quarter 2025 results today, Thursday April 17, 2025 at 10:00 AM Central/11:00 AM Eastern time. The listen-only webcast and related presentation can be accessed via the Investor section of our website. Participants can also register to take part in the call using this online registration link:

https://www.netroadshow.com/events/login?show=7857e434&confId=79909.

Safe Harbor Statement

Certain statements contained in this news release, as well as other information provided from time to time by Badger Meter, Inc. (the “Company”) or its employees, may contain forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those statements. The Company’s results are subject to general economic conditions, variation in demand from customers, continued market acceptance of new products, the successful integration of acquisitions, competitive pricing and operating efficiencies, supply chain risk, material and labor cost increases, tax reform and foreign currency risk. See the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission for further information regarding risk factors, which are incorporated herein by reference. Badger Meter disclaims any obligation to publicly update or revise any forward-looking statements as a result of new information, future events or any other reason.

About Badger Meter

With more than a century of water technology innovation, Badger Meter provides comprehensive water management solutions through its BlueEdge® suite. This tailorable portfolio of smart measurement hardware, reliable communications, data visualization and analytics software and ongoing support and industry expertise give customers the edge in optimizing their operations and contributing to the sustainable use and protection of the world’s most precious resource. For more information, visit www.badgermeter.com.

BADGER METER, INC.

 

 

 

 

 

 

 

 

 

 

 

CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS

 

(in thousands, except share and earnings per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31,

 

 

 

 

 

 

2025

 

 

2024

 

 

 

 

 

 

(Unaudited)

 

 

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

 

 

 

$

222,211

 

 

$

196,280

 

 

 

 

 

 

 

 

 

 

 

Cost of sales

 

 

 

 

 

126,774

 

 

 

119,102

 

 

 

 

 

 

 

 

 

 

 

Gross margin

 

 

 

 

 

95,437

 

 

 

77,178

 

 

 

 

 

 

 

 

 

 

 

Selling, engineering and administration

 

 

 

 

 

46,012

 

 

 

40,600

 

 

 

 

 

 

 

 

 

 

 

Operating earnings

 

 

 

 

 

49,425

 

 

 

36,578

 

 

 

 

 

 

 

 

 

 

 

Interest income, net

 

 

 

 

 

(1,334

)

 

 

(1,526

)

Other pension and postretirement (income) costs

 

 

 

 

 

(28

)

 

 

12

 

 

 

 

 

 

 

 

 

 

 

Earnings before income taxes

 

 

 

 

 

50,787

 

 

 

38,092

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

 

 

 

12,389

 

 

 

8,961

 

 

 

 

 

 

 

 

 

 

 

Net earnings

 

 

 

 

$

38,398

 

 

$

29,131

 

 

 

 

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

 

$

1.31

 

 

$

0.99

 

 

 

 

 

 

 

 

 

 

 

 

Diluted

 

 

 

$

1.30

 

 

$

0.99

 

 

 

 

 

 

 

 

 

 

 

Shares used in computation of earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

 

 

29,378,491

 

 

 

29,320,483

 

 

 

 

 

 

 

 

 

 

 

 

Diluted

 

 

 

 

29,564,797

 

 

 

29,494,488

 

BADGER METER, INC.

 

 

 

 

 

 

 

 

 

 

 

 

CONSOLIDATED CONDENSED BALANCE SHEETS

 

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets

March 31,

 

 

December 31,

 

 

 

 

 

 

 

2025

 

 

2024

 

 

 

 

 

 

 

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

 

 

$

131,358

 

 

$

295,305

 

Receivables

 

 

 

 

 

 

111,855

 

 

 

84,325

 

Inventories

 

 

 

 

 

 

149,405

 

 

 

143,408

 

Prepaid expenses and other current assets

 

 

 

 

 

 

18,959

 

 

 

17,078

 

Total current assets

 

 

 

 

 

 

411,577

 

 

 

540,116

 

 

 

 

 

 

 

 

 

 

 

 

Net property, plant and equipment

 

 

 

 

 

 

75,687

 

 

 

74,260

 

Intangible assets, at cost less accumulated amortization

 

 

 

 

 

 

131,091

 

 

 

45,066

 

Other long-term assets

 

 

 

 

 

 

49,703

 

 

 

45,201

 

Goodwill

 

 

 

 

 

 

231,538

 

 

 

111,770

 

Total assets

 

 

 

 

 

$

899,596

 

 

$

816,413

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities and Shareholders’ Equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Payables

 

 

 

 

 

$

73,789

 

 

$

55,659

 

Accrued compensation and employee benefits

 

 

 

 

 

 

17,298

 

 

 

34,912

 

Other current liabilities

 

 

 

 

 

 

49,930

 

 

 

27,634

 

Total current liabilities

 

 

 

 

 

 

141,017

 

 

 

118,205

 

 

 

 

 

 

 

 

 

 

 

 

Deferred income taxes

 

 

 

 

 

 

24,287

 

 

 

3,652

 

Long-term employee benefits and other

 

 

 

 

 

 

92,606

 

 

 

88,324

 

Shareholders’ equity

 

 

 

 

 

 

641,686

 

 

 

606,232

 

Total liabilities and shareholders’ equity

 

 

 

 

 

$

899,596

 

 

$

816,413

 

 

 

 

 

 

 

 

 

 

 

 

BADGER METER, INC.

 

 

 

 

 

 

 

 

 

 

 

CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS

 

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31,

 

 

 

 

 

 

2025

 

 

2024

 

 

 

 

 

 

(Unaudited)

 

 

(Unaudited)

 

Operating activities:

 

 

 

 

 

 

 

 

 

Net earnings

 

 

 

 

$

38,398

 

 

$

29,131

 

Adjustments to reconcile net earnings to net cash provided by operations:

 

 

 

 

 

 

 

 

 

Depreciation

 

 

 

 

 

2,804

 

 

 

2,892

 

Amortization

 

 

 

 

 

5,478

 

 

 

5,118

 

Noncurrent employee benefits

 

 

 

 

 

37

 

 

 

1

 

Stock-based compensation expense

 

 

 

 

 

1,828

 

 

 

1,271

 

Changes in:

 

 

 

 

 

 

 

 

 

Receivables

 

 

 

 

 

(20,497

)

 

 

(9,164

)

Inventories

 

 

 

 

 

(120

)

 

 

(6,405

)

Payables

 

 

 

 

 

16,294

 

 

 

7,960

 

Prepaid expenses and other assets

 

 

 

 

 

(4,107

)

 

 

(8,065

)

Other liabilities

 

 

 

 

 

(7,088

)

 

 

(1,279

)

Total adjustments

 

 

 

 

 

(5,371

)

 

 

(7,671

)

Net cash provided by operations

 

 

 

 

 

33,027

 

 

 

21,460

 

 

 

 

 

 

 

 

 

 

 

Investing activities:

 

 

 

 

 

 

 

 

 

Property, plant and equipment expenditures

 

 

 

 

 

(2,966

)

 

 

(2,676

)

Acquisitions, net of cash acquired

 

 

 

 

 

(184,937

)

 

 

(3,000

)

Net cash used for investing activities

 

 

 

 

 

(187,903

)

 

 

(5,676

)

 

 

 

 

 

 

 

 

 

 

Financing activities:

 

 

 

 

 

 

 

 

 

Dividends paid

 

 

 

 

 

(10,017

)

 

 

(7,942

)

Proceeds from exercise of stock options

 

 

 

 

 

68

 

 

 

230

 

Net cash used for financing activities

 

 

 

 

 

(9,949

)

 

 

(7,712

)

Effect of foreign exchange rates on cash

 

 

 

 

 

878

 

 

 

(544

)

 

 

 

 

 

 

 

 

 

 

(Decrease) increase in cash and cash equivalents

 

 

 

 

 

(163,947

)

 

 

7,528

 

Cash and cash equivalents – beginning of period

 

 

 

 

 

295,305

 

 

 

191,782

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents – end of period

 

 

 

 

$

131,358

 

 

$

199,310

 

 

 

 

 

 

 

 

 

 

 

 

Karen Bauer

(414) 371-7276

[email protected]

KEYWORDS: United States North America Wisconsin

INDUSTRY KEYWORDS: Other Energy Utilities Agriculture Natural Resources Sustainability Environment Energy Other Natural Resources

MEDIA:

Logo
Logo

Charles River Associates (CRA) to Host First-Quarter Fiscal 2025 Financial Results Conference Call on May 1

Charles River Associates (CRA) to Host First-Quarter Fiscal 2025 Financial Results Conference Call on May 1

Conference Call to be Webcast Live at 10:00 a.m. ET

BOSTON–(BUSINESS WIRE)–Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that the company will webcast its first-quarter 2025 financial results conference call on Thursday, May 1, 2025 at 10:00 a.m. ET. The conference call will be hosted by President and Chief Executive Officer Paul Maleh and Chad Holmes, CRA’s Chief Corporate Development Officer and interim Chief Financial Officer.

To listen to a live webcast of the call, please visit the “Investor Relations” section of CRA’s website at http://www.crai.com. To listen to the call via telephone, dial (877) 709-8155 or (201) 689-8881. Prior to the call, CRA will post the press release announcing its financial results and supplemental financial information, including prepared CFO remarks, on the “Investor Relations” section of its website. An archived version of the webcast, press release, and financial information will be available on CRA’s website for one year.

About Charles River Associates (CRA)

Charles River Associates® is a leading global consulting firm specializing in economic, financial, and management consulting services. CRA advises clients on economic and financial matters pertaining to litigation and regulatory proceedings, and guides corporations through critical business strategy and performance-related issues. Since 1965, clients have engaged CRA for its unique combination of functional expertise and industry knowledge, and for its objective solutions to complex problems. Headquartered in Boston, CRA has offices throughout the world. Detailed information about Charles River Associates, a registered trade name of CRA International, Inc., is available at www.crai.com. Follow us on LinkedIn, Instagram, and Facebook.

Chad Holmes

Charles River Associates

[email protected]

312-377-2322

Nicholas Manganaro

Sharon Merrill Advisors

[email protected]

617-542-5300

KEYWORDS: United States North America Massachusetts

INDUSTRY KEYWORDS: Consulting Legal Professional Services Finance

MEDIA:

CyberArk Announces 2025 Identity Security Impact Customer Award Winners

CyberArk Announces 2025 Identity Security Impact Customer Award Winners

Award program celebrates customers building transformative identity-centric programs that support security, speed and agility in modern enterprise environments

NEWTON, Mass. & PETACH TIKVA, Israel–(BUSINESS WIRE)–CyberArk (NASDAQ: CYBR), the global leader in identity security, announced its 2025 Identity Security Impact Customer Award winners at the company’s annual flagship conference, CyberArk IMPACT ‘25, held in Boston. With identity being a top attack vector, identity security is one of the most critical components of a comprehensive cybersecurity strategy. These awards recognize CyberArk customers who have demonstrated their commitment to rethink and redefine how they secure all identities, both human and machine.

“This year, we received a record number of high-quality award applications from companies across the globe, making for exceptionally strong competition. Congratulations to our 2025 award winners,” said Shahar Layani, Chief Customer Officer at CyberArk. “The organizations we have recognized are leading the way in advancing identity security practices for modern use cases, creating a secure foundation for their digital transformation. Their commitment to reducing risk while driving business growth is inspiring, and we’re excited to honor their exceptional efforts.”

The CyberArk 2025 Identity Security Impact Customer Award winners are:

  • Northern Trust: Delivered a massive cyber risk reduction program
  • BMW Group: Used CyberArk as part of a major digital transformation
  • IHG Hotels & Resorts: Demonstrated excellence in instituting zero trust principles
  • Cisco: Executed identity security projects with unparalleled speed and efficiency

About CyberArk

CyberArk (NASDAQ: CYBR) is the global leader in identity security, trusted by organizations around the world to secure human and machine identities in the modern enterprise. CyberArk’s AI-powered Identity Security Platform applies intelligent privilege controls to every identity with continuous threat prevention, detection and response across the identity lifecycle. With CyberArk, organizations can reduce operational and security risks by enabling zero trust and least privilege with complete visibility, empowering all users and identities, including workforce, IT, developers and machines, to securely access any resource, located anywhere, from everywhere. Learn more at cyberark.com.

Copyright © 2025 CyberArk Software. All Rights Reserved. All other brand names, product names, or trademarks belong to their respective holders.

Investor Relations:

Srinivas Anantha, CFA

CyberArk

617-558-2132

[email protected]

Media:

Rachel Gardner

CyberArk

603-531-7229

[email protected]

KEYWORDS: United States North America Israel Middle East Massachusetts

INDUSTRY KEYWORDS: Technology Mobile/Wireless Security Telecommunications Software Networks Internet Hardware Artificial Intelligence

MEDIA:

Logo
Logo

American Rebel (NASDAQ:AREB) Congratulates Tony Stewart on History-Making Victory in NHRA Top Fuel Event at Las Vegas Motor Speedway


First Driver to Win NASCAR Cup Race, IndyCar Race, USAC Triple Crown Championship and NHRA Pro Event


American Rebel Light Beer Sponsorship of Tony Stewart Racing Drivers Tony Stewart and Matt Hagan Celebrate Stewart Win and Head to Charlotte for American Rebel Light NHRA 4-Wide Nationals April 25 – 27 at zMAX Dragway at Charlotte Motor Speedway

Nashville, TN, April 17, 2025 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB) (“American Rebel” or the “Company”), creator of American Rebel Beer (americanrebelbeer.com) and a designer, manufacturer, and marketer of branded safes, personal security and self-defense products and apparel (americanrebel.com), would like to congratulate Tony Stewart on his history-making victory in the NHRA Top Fuel Dragster (nhra.com) this past weekend at The Strip at Las Vegas Motor Speedway. Tony is the first driver to win a NASCAR Cup Series race, an IndyCar race, a USAC Triple Crown Championship and an NHRA Pro Event. The American Rebel Light Beer sponsorship of Tony Stewart Racing (tsrnitro.com) drivers Tony Stewart and Matt Hagan proudly celebrate the Stewart win as this history-making victory draws tremendous attention to the American Rebel Light sponsorship. The Stewart victory is also very emotional for the American Rebel team as we know how much this victory means to Tony and Leah personally.

“I haven’t been around the NHRA Mission Foods Drag Racing Series very long, but I realized it takes a lot to win one of these Top Fuel races,” said Tony Stewart. “In my career, I’ve never had to wait over a year to win a race. We always figured it out pretty quickly and we won. We needed this win. It’s been so stressful for everyone since Leah (Pruett – Stewart’s wife) nearly won the World Top Fuel Championship in 2023 when it came down to the final round of the whole season.”

Tony Stewart replaced Leah Pruett as the driver of the Tony Stewart Racing NHRA Top Fuel Dragster at the beginning of the 2024 season. Tony and Leah were married in 2021 and Leah asked Tony to drive her car in the Top Fuel series as the couple set out to start a family. Tony drove in the Top Alcohol series, a tier below Top Fuel, in 2023.

“When your wife wants to try to start a family and wants you to driver her car, what are you going to say?” continued Stewart. “We had a lot of changes for the team because my body weight is different. Car tubing is different, and it just takes time. It was frustrating as we just couldn’t get on a path to make consistent gains last year. Two years ago, I won my first NHRA national event in the Top Alcohol Dragster here at Las Vegas with McPhillips Racing, and now I win my first Top Fuel national event at the Strip. It’s pretty damn cool. I’ve been a motorsports fan my whole life, and I think we made racing history with the Top Fuel win. I’m not sure if there has ever been a driver to win a NASCAR Cup race, an IndyCar race, the USAC Triple Crown championship and an NHRA Pro event (Top Fuel). To do it with our team and our family was very emotional. When Leah brought Dom (their newborn son) up on stage in victory lane, my heart stopped. I got so emotional there. That is a feeling I have never had in my life before. The Four Wide setup is the equalizer for me. I’m used to racing with many cars around me. It’s tough for the guys who are not used to four cars racing at once. We can’t get to Charlotte fast enough with the next four-wide setup. I love the format.”

The next event on the NHRA Misson Foods Drag Racing Series schedule is the American Rebel Light NHRA 4-Wide Nationals April 25 – 27 at the Charlotte Motor Speedway.

“I couldn’t be happier for Tony and Leah as I know how much the victory in Las Vegas means to them both,” said American Rebel CEO Andy Ross. “Our relationship started out as a sponsorship, turned into a friendship and now it’s family. Tony, Matt and Leah have been a big part of our incredible success opening up distributors for American Rebel Light Beer across the country. Various consultants told me opening up distributors was next to impossible, but American Rebel has proven them wrong because we have a real 12-year organic story of how we got here, and Tony, Matt and Leah’s support have poured patriotic fuel all over the fire we had already started. I can’t thank them enough for everything they’ve done.”

American Rebel is an associate sponsor on the Tony Stewart driven Top Fuel Dragster and the Matt Hagan driven Funny Car for all 20 races of the NHRA Mission Foods 2025 season as well as the primary sponsor of the Matt Hagan Funny Car for five races, including the American Rebel Light NHRA 4-Wide Nationals at Charlotte Motor Speedway, and the primary sponsor of the Tony Stewart Top Fuel Dragster for one race during the 2025 season. Being a sponsor provides opportunities for vast exposure during the race broadcasts on Fox Sports, Fox Sports 1 (FS1) and Fox Sports 2 (FS2). Ratings for NHRA telecasts are very strong and visibility continues to expand through additional streaming options through NHRA.tv.

In addition to the strong television viewership of NHRA racing, NHRA has unveiled exciting opportunities for digital media and content creators for the 2025 NHRA Mission Foods Drag Racing Series season. Aiming to change the way influencers, content creators and digital media members experience drag racing, NHRA is working to expand its reach across social media platforms with its Cornwell Tools Burnout Box Content Creator Zone. This expansion and emphasis in the digital media space will significantly benefit American Rebel.

American Rebel has also benefitted from the relationship with Tony Stewart Racing through the social media reach of Tony Stewart, Matt Hagan and Leah Pruett. Tony Stewart has nearly 750,000 followers on X (@TonyStewart) and over 250,000 followers on Instagram (@tsrsmoke). Matt Hagan has nearly 150,000 followers on Instagram (@matthagan_fc) and Leah Pruett has nearly 400,000 followers on Instagram (@leah.pruett).

“Tony, Matt and Leah are such an important part of our story,” said Andy Ross. “Tony is a legendary NASCAR driver who may be the most versatile race car driver in history, having also driven in NASCAR, IndyCar, USAC, NHRA and just about anything with wheels. And Matt has 52 NHRA national event wins and is one of only four legendary Funny Car drivers to win four championships (John Force, Don Prudhomme and Kenny Bernstein are the others) and Leah has kicked in doors as a Top Fuel driver and she continues to provide unparalleled support for American Rebel at the track and on social media. Our distributors love our connection with Tony Stewart Racing as American Rebel Light Beer connects with our customers through this sponsorship.”

It’s been said that Andy Ross wrote the most on-brand drag racing song ever with his “Nitro Lightning” that he wrote for Matt Hagan. The song gets played at the track nearly every race weekend and even has been referenced on the Fox broadcasts. Andy has performed concerts at the Texas Motorplex and the Bradenton Motorsports Park after race events and is scheduled to perform this year at the American Rebel Light NHRA 4-Wide Nationals in Concord, NC.

“What’s more American Rebel than rock ‘n’ roll and drag racing? I love victory lane and bringing the party,” said Andy Ross. “Drag racing fans are the perfect demo for American Rebel Beer and we’re looking forward to continuing this relationship a long time.”

Primary sponsorship dates for American Rebel Beer on the Matt Hagan Funny Car are April 25 – 27 at the American Rebel Light NHRA 4-Wide Nationals in Concord, NC; June 20 – 22 at the Virginia NHRA Nationals at North Dinwiddle, VA; August 14 – 17 at the Lucas Oil NHRA Nationals in Brainerd, MN; September 26 – 28 at the NHRA Midwest Nationals near St. Louis, MO; and October 30 – November 2 at the NHRA Nevada Nationals in Las Vegas, NV. American Rebel Beer will also be a primary sponsor for the Tony Stewart Top Fuel Dragster on September 26 – 28 at the NHRA Midwest Nationals near St. Louis, MO.

About American Rebel Light Beer

Produced in partnership with AlcSource, American Rebel Light Beer (americanrebelbeer.com) is a domestic premium light lager celebrated for its exceptional quality and patriotic values. It stands out as America’s Patriotic, God-Fearing, Constitution-Loving, National Anthem-Singing, Stand Your Ground Beer.

American Rebel Light is a Premium Domestic Light Lager Beer – All Natural, Crisp, Clean and Bold Taste with a Lighter Feel. With approximately 100 calories, 3.2 carbohydrates, and 4.3% alcoholic content per 12 oz serving, American Rebel Light Beer delivers a lighter option for those who love great beer but prefer a more balanced lifestyle. It’s all natural with no added supplements and importantly does not use corn, rice, or other sweeteners typically found in mass produced beers.

About Tony Stewart Racing

Headquartered in Brownsburg, Indiana, Tony Stewart Racing (TSR) Nitro fields two entries in the NHRA Mission Foods Drag Racing Series. After more than four decades of racing around in circles, Tony Stewart embarked on a straight and narrow path, albeit more than 300 mph. The championship-winning racecar driver who has successfully transitioned to being a championship-winner team owner, formed the TSR nitro team in 2021, with 2022 marking the team’s first season in competition. Matt Hagan pilots the Funny Car and Tony Stewart took over driving duties in 2024 for wife Leah Pruett in the Top Fuel dragster as they started a family. Hagan is a four-time Funny Car champion (2011, 2014, 2020 and 2023) from Christiansburg, Virginia. Stewart hails from Columbus, Indiana and earned his first Top Fuel victory at the 2025 NHRA Four-Wide Nationals in Las Vegas. He also won the 2024 NHRA Rookie of the Year title. Stewart finished second in the 2023 Top Alcohol Dragster championship standings.

About American Rebel Holdings, Inc.

American Rebel Holdings, Inc. (NASDAQ: AREB) has operated primarily as a designer, manufacturer and marketer of branded safes and personal security and self-defense products and has recently transitioned into the beverage industry through the introduction of American Rebel Beer. The Company also designs and produces branded apparel and accessories. To learn more, visit americanrebelbeer.com or americanrebel.com. For investor information, visit americanrebelbeer.com/investor-relations.

American Rebel Holdings, Inc.

[email protected]

American Rebel Beverages, LLC

Todd Porter, President
[email protected]

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. American Rebel Holdings, Inc., (NASDAQ: AREB; AREBW) (the “Company,” “American Rebel,” “we,” “our” or “us”) desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbor legislation. The words “forecasts” “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements primarily on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy, and financial needs. Important factors that could cause actual results to differ from those in the forward-looking statements include benefits of a launch party, actual launch timing and availability of American Rebel Beer, success and availability of the promotional activities, our ability to effectively execute our business plan, and the Risk Factors contained within our filings with the SEC, including our Annual Report on Form 10-K for the year ended December 31, 2024. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise, except as may be required by law.

Company Contact:

[email protected]

[email protected]

Attachment



PAX Health Acquires Richardson Psychiatric Associates, Expanding Mental Health Services for Adults, Adolescents, and Families

PR Newswire


RED BANK, N.J.
, April 17, 2025 /PRNewswire/ — PAX Health, a leading behavioral healthcare company backed by HCAP Partners and funds managed by Hamilton Lane (Nasdaq:HLNE), today announced its acquisition of Richardson Psychiatric Associates, a comprehensive outpatient psychiatric practice serving adults, adolescents, children, and families.

This strategic acquisition enhances PAX Health’s portfolio of mental health services and expands its geographic footprint in Western Pennsylvania, strengthening the company’s ability to deliver high-quality psychiatric care across diverse patient populations.

“Richardson Psychiatric Associates has established an outstanding reputation for providing personalized mental health treatment in a compassionate environment,” said Anthony DeSena, CEO of PAX Health. “Dr. Richardson and his team’s expertise in psychiatric evaluations, medication management, and specialized therapeutic approaches adds significant value to our service offerings and aligns perfectly with our mission to improve access to comprehensive behavioral healthcare, further supporting the expansion of our geographic footprint.”

Co-founded by Dr. W. Randolph Richardson and Lisa Richardson, PMHNP-BC, Richardson Psychiatric Associates offers a wide range of services including psychiatric evaluations, medication management, and various evidence-based therapeutic modalities such as Cognitive Behavioral Therapy, Trauma Therapy, Art Therapy, and Grief Therapy. Dr. Richardson has been practicing psychiatry since 1991, while Lisa has worked in psychiatry since 1987, providing psychiatric evaluations and medication management to patients of all ages.

“We are excited about the partnership and are looking forward to the opportunity to help grow PAX’s presence in Pennsylvania,” said Dr. W. Randolph Richardson, MD, Co-Founder of Richardson Psychiatric Associates. “We anticipate being able to use our thirty-plus years of knowledge of the Western Pennsylvania market to improve the availability of high-quality mental health services in our area. We are hopeful that we will have a long-term legacy for our practice as we build our partnership with PAX through the coming years.”

“We look forward to continuing the patient-centered and compassionate care we currently provide in conjunction with our new PAX partners, now with a new ability to grow and expand our services to a broader community,” added Lisa Richardson, CRNP, Co-Founder of Richardson Psychiatric Associates.

This acquisition represents another significant step in PAX Health’s growth strategy, supported by healthcare-focused private equity firm HCAP Partners and global investment management firm Hamilton Lane. The integration will enhance PAX Health’s ability to deliver customized behavioral health solutions while preserving Richardson Psychiatric Associates’ established approach to patient care.

About PAX Health

PAX Health is a leading behavioral health company dedicated to providing innovative and comprehensive solutions for mental health and well-being. Through strategic integration of best practices and resources, PAX Health delivers tailored solutions for individuals, businesses, and communities seeking comprehensive behavioral health services.

About Richardson Psychiatric Associates

Richardson Psychiatric Associates offers outpatient psychiatric treatment for adults, adolescents, children, and families. Co-founded by Dr. W. Randolph Richardson and Lisa Richardson, PMHNP-BC, the practice provides services including psychiatric evaluations, medication management, and various therapeutic approaches in a comfortable, supportive environment.

Dr. Richardson is Board Certified in Psychiatry by the American Board of Psychiatry and Neurology. He completed his medical school training at Emory University School of Medicine and completed Psychiatry Residency training at the University of Pittsburgh Medical Center. Lisa Richardson holds a master’s degree in Psychiatric Mental Health Nursing from the University of Pittsburgh and Post-Master’s Certificates for Psychiatric Mental Health Nurse Practitioner from both Drexel and Rush Universities. She is board certified as a Psychiatric Mental Health Nurse Practitioner Across the Lifespan by the American Nurses Credentialing Center.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/pax-health-acquires-richardson-psychiatric-associates-expanding-mental-health-services-for-adults-adolescents-and-families-302431022.html

SOURCE PAX Health

DTE Energy schedules first quarter 2025 earnings release, conference call

DETROIT, April 17, 2025 (GLOBE NEWSWIRE) — DTE Energy (NYSE:DTE) will announce its first quarter 2025 earnings before the market opens Thursday, May 1, 2025.

The company will conduct a conference call to discuss earnings results at 9:00 a.m. ET the same day.

Investors, the news media and the public may listen to a live internet broadcast of the call at dteenergy.com/investors. The telephone dial-in number in the U.S. and Canada toll free is: (888) 510-2008. The telephone dial-in USA toll is: (646) 960-0306 and the Canada dial-in toll is: (289) 514-5035. The passcode is 4987588. The webcast will be archived on the DTE Energy website at dteenergy.com/investors.

About DTE Energy  
DTE Energy (NYSE:DTE) is a Detroit-based diversified energy company involved in the development and management of energy-related businesses and services nationwide. Its operating units include an electric company serving 2.3 million customers in Southeast Michigan and a natural gas company serving 1.3 million customers across Michigan. The DTE portfolio also includes energy businesses focused on custom energy solutions, renewable energy generation, and energy marketing and trading. DTE has continued to accelerate its carbon reduction goals to meet aggressive targets and is committed to serving with its energy through volunteerism, education and employment initiatives, philanthropy, emission reductions and economic progress. Information about DTE is available at dteenergy.com, empoweringmichigan.com, x.com/DTE_Energy and facebook.com/dteenergy

For more information, members of the media may contact:
Dan Miner, DTE Energy: 313.235.5555

For further information, analysts may call:

Matt Krupinski, DTE Energy: 313.235.6649
John Dermody, DTE Energy: 313.235.8750



Sallie Justice
DTE Energy
313.235.5555

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Disease Test for Early Detection of Kidney Damage

  • Regulatory milestone enables commercial expansion into high-need international market
  • 10-minute test detects early signs of kidney damage using a simple urine sample
  • Addresses global public health burden of Chronic Kidney Disease (CKD), with high relevance in the UAE

IRVINE, Calif., April 17, 2025 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced diagnostic solutions, announced that its Fortel® Kidney Disease (Microalbumin) Test has been approved for sale by the United Arab Emirates (UAE) Ministry of Health and Prevention. This key regulatory milestone enables Biomerica to offer its innovative test across the UAE, a region facing a high burden of chronic kidney disease (CKD).

The Fortel® Kidney Disease Test is a rapid, easy-to-use diagnostic tool that provides accurate results in 10 minutes using a urine sample. By detecting low levels of microalbumin in urine (a critical early marker), the test can enable the early detection of kidney disease. Individuals with diabetes, hypertension, obesity and those over the age of 65 are at significantly increased risk for developing chronic kidney disease (CKD) and should be tested frequently. CKD is a worldwide public health problem that is highly underrecognized and more than 80% of at-risk patients are not diagnosed. Kidney disease enhances the risk of major non-communicable diseases including ischemic heart disease, stroke, cancer, etc. By 2040, CKD is projected to be the 5th highest cause of years of life lost globally.

Early detection of CKD allows for timely intervention that can slow or prevent progression to end-stage renal disease, requiring dialysis or kidney transplantation. In addition to reducing morbidity and mortality, early diagnosis can also lower the substantial economic burden associated with disease progression.

Diabetes and Hypertension: Two Major Risk Factors in the UAE

In the UAE, diabetes and hypertension are two of the most significant risk factors for chronic kidney disease (CKD). According to the International Diabetes Federation, over 12% of adults in the UAE live with diabetes, while regional studies estimate that 29% to 35% of the population have hypertension. Both conditions are leading contributors to CKD and often go undiagnosed until significant kidney damage has occurred. CKD is often referred to as a “silent disease” because it typically shows few or no symptoms until it reaches an advanced and potentially irreversible stage. This makes early detection especially important.

“The Fortel® Kidney Disease Test addresses a critical need in preventative healthcare by allowing the possible detection of kidney disease before symptoms appear,” said Zack Irani, CEO of Biomerica. “With the high prevalence of diabetes and hypertension in the UAE, this approval supports our mission to bring life-saving diagnostic tools to communities where they are most needed.”

Supporting Healthcare Access in the Middle East

This approval builds on Biomerica’s growing presence in the Middle East, following the regional success of its EZ Detect™ Colon Disease Test and other innovative diagnostic products. The Company has established partnerships with leading distributors and healthcare providers in the UAE to allow the Fortel® Kidney Disease Test to be available across the country.

A Commitment to Early Detection and Better Outcomes

Biomerica remains dedicated to expanding access to cost-effective, high-quality diagnostics that empower patients and healthcare professionals. The Fortel® Kidney Disease Test is part of a broader portfolio of solutions designed to improve patient outcomes through early detection and personalized care.

About Biomerica (NASDAQ:

BMRA

)

Biomerica, Inc. (www.biomerica.com) is a global biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physicians’ offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. The Company’s products are designed to enhance the health and well-being of people, while reducing total healthcare costs. Biomerica primarily focuses on gastrointestinal and inflammatory diseases where the Company has multiple diagnostic and therapeutic products in development.

The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements. Certain information included in this press release (as well as information included in oral statements or other written statements made or to be made by Biomerica) contains statements that are forward-looking, such as statements relating to the Company’s current and future sales, revenues, overhead, expenses, cost of goods, operations and earnings, efficacy of the Company’s products and tests including the Fortel® Kidney Disease Test, FDA and/or international regulatory authorization for the Company’s products to be marketed and sold, including the Fortel® Kidney Disease Test, and the Company’s other current and future products, the possible expansion in to other markets, uniqueness of the Company’s products, accuracy of the Company’s tests and products, pricing of the Company’s test kits, domestic and/or international market adoption and acceptance and demand for the Company’s products including the Fortel® Kidney Disease Test, future use of the Company’s products by physicians to treat their patients, potential revenues from the sale of current or future products. Such forward-looking information involves important risks and uncertainties that could significantly affect anticipated results, in the future, including, without limitation: earnings and other financial results; results of studies testing the efficacy of the Company’s inFoods tests and other products; regulatory approvals necessary prior to commercialization of the Company’s products; availability of the Company’s test kits and other products; capacity, shipping logistics, resource and other constraints on our suppliers; dependence on our third party manufacturers; dependence on international shipping carriers; governmental import/export regulations; demand for our various tests and other products; competition from other similar products and from competitors that have significantly more financial and other resources available to them; governmental virus control regulations that make it difficult or impossible for the company to maintain current operations; regulatory compliance and oversite, and the Company’s ability to obtain patent protection on any aspects of its diagnostic or therapeutic technologies. Accordingly, such results may differ materially from those expressed in any forward-looking statements made by or on behalf of Biomerica. Additionally, potential risks and uncertainties include, among others, fluctuations in the Company’s operating results due to its business model and expansion plans, downturns in international and or national economies, the Company’s ability to raise additional capital, the competitive environment in which the Company will be competing, and the Company’s dependence on strategic relationships. The Company is under no obligation to update any forward-looking statements after the date of this release.

Corporate Contact:

Zack Irani | CEO
p. 949.645.2111
www.biomerica.com

Source: Biomerica



Xometry’s Marketplace Has Generated Nearly $1 Billion In Revenue For America’s Small- And Medium Manufacturers

  • From Local Shops to Global Reach: Xometry Helps Manufacturers Thrive And Grow, Reaching New Customers, Reinvesting In Their Business And Attracting Top Talent
  • The Company’s Annual “Excellence In Manufacturing” Awards Honors U.S. Manufacturers Who Deliver Exceptional Quality
  • Wisconsin-Based JR Metal Works, A Multi-Year Winner, Describes Xometry As A “Horsepower Multiplier” For His Business

NORTH BETHESDA, Md., April 17, 2025 (GLOBE NEWSWIRE) — Xometry (NASDAQ: XMTR), the global marketplace digitizing manufacturing and driving greater supply chain resiliency, today announced that its AI-powered, on-demand custom manufacturing marketplace has generated nearly $1 billion in revenue for America’s small- and medium manufacturers from Jan. 1, 2020 – March 31, 2025.

“America’s manufacturers are deeply rooted in their local communities and play a critical role in our national and global economies,” said Randy Altschuler, CEO of Xometry. “The Xometry Marketplace helps them reach new customers, re-invest in growth, and hire and train skilled talent. We see the impact every day through our partnerships across the country.”

In addition to creating nearly $1 billion in revenue for U.S. manufacturers on its platform, Xometry through its annual “Excellence in Manufacturing” awards program recognizes exceptional suppliers who deliver quality products.

This year’s honorees represent all 48 contiguous states and encompass nearly every type of manufacturing technology – from CNC machining and injection molding to sheet metal fabrication and metal- and plastic 3D printing.

One standout honoree is JR Metal Works, a Green Bay, Wisc.-based custom fabricator of sheet metal, pipe and plate products. A five-time award recipient, JR Metal Works continues to raise the bar for quality and service.

“Since high school, I dreamed of having my own metal fabrication shop. In 2016, I opened JR Metal Works with a mission of providing customers excellent customer service, quality and a premium experience,” Jesse Kleiman, owner of JR Metal Works, said. “Since we began working with Xometry in 2019, we’ve been able to purchase additional equipment, grow our team and reach new customers around the world. Xometry is a horsepower multiplier for our business.”

Today, more than 4,375 global suppliers are active on the Xometry Marketplace. A significant majority of marketplace revenue flows to the company’s growing U.S. supplier network.

In a rapidly changing environment, agility is everything. As more manufacturers reshore operations and seek domestic partners, they’re also turning to Xometry to digitize and future-proof their businesses. Xometry’s robust suite of digital tools benefits both buyers and suppliers:

  • For buyers, Xometry offers Teamspace, enterprise-wide collaboration software that unites engineers, managers and purchasing executives to expedite procurement of custom-manufacturing services.
  • For suppliers, Xometry offers Workcenter, a cloud-based ‘manufacturing execution system’ (MES) that digitizes operations and serves as a gateway to the Xometry platform. Xometry also offers integrated financial services to help manufacturers maintain healthy cash flow.

According to Xometry’s recent “American Manufacturing Resurgence” poll, conducted with John Zogby Strategies, 70% of manufacturing CEOs (at companies with revenue from $5 million to $500 million) are embracing AI to boost operational efficiencies. Nearly half have reshored some or all of their operations.

“America’s manufacturers are resilient and can meet any moment,” Altschuler said. “Xometry was purpose-built to help them move faster, adapt to change and drive innovation.”

About Xometry
Xometry’s (NASDAQ: XMTR) AI-powered marketplace, popular Thomasnet® industrial sourcing platform and suite of cloud-based services are rapidly digitizing the manufacturing industry. Xometry provides manufacturers the critical resources they need to grow their business and makes it easy for buyers to get the instant pricing and lead times to create locally resilient supply chains. The Xometry Instant Quoting Engine® leverages millions of data to analyze complex parts in real time, matches buyers with the right suppliers globally, and provides accurate pricing and lead times. Learn more at www.xometry.com or follow @xometry.

Media Contacts:
Matthew Hutchison
Chief Communications Officer
[email protected]

Investor Contact:
Shawn Milne
VP, Investor Relations
240-335-8132
[email protected]



Norwood Financial Corp announces First Quarter 2025 Results

Quarterly Highlights:

  • Fully diluted EPS of $0.63, a 14.5% increase over the same period in 2024
  • Return on assets rises to over 1.00%.
  • Net interest margin increased 30 basis points vs. the prior quarter and 11 basis points over the prior year.
  • Loans grew at a 13.5% annualized rate during the first quarter.
  • Capital continues to improve on increased earnings and lower AOCI adjustment.

HONESDALE, Pa., April 17, 2025 (GLOBE NEWSWIRE) — Norwood Financial Corp (Nasdaq Global Market-NWFL) and its subsidiary, Wayne Bank, announced results for the three months March 31, 2025.

Jim Donnelly, President and Chief Executive Officer of Norwood Financial Corp and Wayne Bank, stated, “The actions that we took in December 2024 to improve our capital and earnings have given us a great start to 2025. The portfolio repositioning has improved our net interest margin. That, coupled with strong annualized growth in loans and deposits, put us on a positive trajectory for 2025. We continue to benefit from lower deposit costs together with higher assets yields and our deposit growth has allowed us to lower our use of wholesale borrowings.”

Mr. Donnelly continued, “The capital that we raised in December 2024, has strengthened our balance sheet and will allow our Company to better weather any headwinds that come with global uncertainty. Although we do not have any international business per se, we do have customers who may have exposure to developing trade conditions. Because we are a community bank we are contacting our customers to determine how we can best assist them, if necessary. Additionally, we are being prudent regarding the opportunities in front of us, taking the time to assess the effects of changing economic circumstances.”

Selected Financial Highlights

(dollars in thousands, except
per share data)
Year-Over Year Linked Quarter Adjusted Linked Quarter1  
  3 Months Ended 3 Months Ended 3 Months Ended  
  Mar-25 Mar-24 Change Dec-24 Change Dec-24 Change  
Net interest income 17,857   14,710   3,147 16,625   1,232 16,625   1,232  
Net interest spread (fte) 2.61%   2.08%   53 bps 2.31%   30 bps 2.31%   30 bps  
Net interest margin (fte) 3.30%   2.80%   50 bps 3.04%   26 bps 3.04%   26 bps  
Net income (loss) 5,773   4,433   1,340 (12,651)   18,424 3,119   2,654  
Diluted earnings per share 0.63   0.55   0.08 -1.54   -2.09 0.38   0.25  
Return on average assets 1.01%   0.80%   21 bps -2.19%   320 bps 0.54%   47 bps  
Return on tangible equity 12.40%   11.65%   75 bps -30.77%   (4,317 bps) 7.59%   481 bps  
       

1 – The above table includes non-GAAP financial measures excluding the one-time $20.0 million net realized loss incurred in the fourth quarter as a result of the repositioning of our investment portfolio. Please see “Non-GAAP Financial Measures” below for a reconciliation of all non-GAAP financial measures.

Discussion of financial results for the three months ended March 31, 2025:

  • The Company had net income of $5.8 million for the three months ended March 31, 2025, an increase $1.3 million over the same period last year.
  • Net interest income increased during the first quarter of 2025 compared to the first quarter of 2024 due to increases in asset yields which outpaced increases in yields on liabilities.
  • Correspondingly, the net interest margin in the first quarter of 2025 was 3.30% compared to 2.80% in the first quarter of 2024.
  • The efficiency ratio for the first quarter of 2025 was 59.7% compared to 70.6% in the first quarter of 2024.
  • As of March 31, 2025, total assets were $2.376 billion, compared to $2.260 billion at March 31, 2024, an increase of 5.07%.
  • Loans receivable were $1.771 billion at March 31 2025, compared to $1.621 billion at March 31, 2024, an increase of 9.24%.
  • Total deposits were $2.004 billion at March 31 2025, compared to $1.839 billion at March 31, 2024, an increase of 9.00%.
  • Tangible Common Equity was 8.16% as of March 31, 2025, versus 6.80% at March 31, 2024.
  • Tangible Book Value per share increased $0.81 from $19.85 at December 31, 2024 to $20.66 at March 31, 2025.

Norwood Financial Corp is the parent company of Wayne Bank, which operates from sixteen offices throughout Northeastern Pennsylvania and fourteen offices in Delaware, Sullivan, Ontario, Otsego and Yates Counties, New York. The Company’s stock trades on the Nasdaq Global Market under the symbol “NWFL”.

Non-GAAP Financial Measures

This release references adjusted net income, adjusted diluted earnings per share, adjusted return on average assets and adjusted return on tangible equity, all of which are non-GAAP (Generally Accepted Accounting Principles) financial measures. Adjusted values were derived by reversing the effect of loss on sale of securities in December 2024 along with the attendant tax effect. We believe the presentation of adjusted net income, adjusted diluted earnings per share, adjusted return on average assets and adjusted return on tangible equity ensures comparability of these measures as the portfolio restructuring is not something the Company expects to be a recurring event.


Adjusted Return on Average Assets
     
(Dollars in thousands)      
  Three Months Ended
  December 31, 2024
Net (loss) income $ (12,651)  
Average assets   2,299,732  
Return on average assets (annualized)   -2.19 %
Net (loss) income   (12,651)  
Net realized losses on sale of securities   19,962  
Tax effect at 21%   (4,192)  
Adjusted Net Income (Non-GAAP)   3,119  
Average assets   2,299,732  
Adjusted return on average assets (annualized)      
(Non-GAAP)   0.54 %
       
       

Adjusted Return on Average Tangible Shareholders’ Equity
     
(Dollars in thousands)      
       
  Three Months Ended
  December 31, 2024
Net (loss) income $ (12,651)  
Average shareholders’ equity   192,981  
Average intangible assets   29,424  
Average tangible shareholders’ equity   163,557  
Return on average tangible shareholders’ equity (annualized)   -30.77 %
Net (loss) income   (12,651)  
Net realized losses on sale of securities   19,962  
Tax effect at 21%   (4,192)  
Adjusted Net Income (Non-GAAP)   3,119  
Average tangible shareholders’ equity   163,557  
Adjusted return on average shareholders’ equity (annualized)      
(Non-GAAP)   7.59 %
       
       

Adjusted Earnings Per Share
     
(Dollars in thousands)      
       
  Three Months Ended
  December 31, 2024
GAAP-Based Earnings Per Share, Basic $ (1.54)  
GAAP-Based Earnings Per Share, Diluted $ (1.54)  
Net (Loss) Income   (12,651)  
Net realized losses on sale of securities   19,962  
Tax effect at 21%   (4,192)  
Adjusted Net Income (Non-GAAP)   3,119  
Adjusted Earnings per Share, Basic (Non-GAAP) $ 0.38  
Adjusted Earnings per Share, Diluted (Non-GAAP) $ 0.38  

The following table reconciles average equity to average tangible equity:

   
For the Period Ended
(dollars in thousands)  
March 31
     
2025
     
2024
 
             
Average equity   $ 218,194     $ 182,088  
Average goodwill and other intangibles     (29,409 )     (29,476 )
Average tangible equity   $ 188,785     $ 152,612  
             

Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 contains safe harbor provisions regarding forward-looking statements. When used in this discussion, the words “believes”, “anticipates”, “contemplates”, “expects”, “bode”, “future performance” and similar expressions are intended to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, which could cause actual results to differ materially from those projected. Those risks and uncertainties include, among other things, changes in federal and state laws, changes in interest rates, our ability to maintain strong credit quality metrics, our ability to have future performance, our ability to control core operating expenses and costs, demand for real estate, government fiscal and trade policies, cybersecurity and general economic conditions. The Company undertakes no obligation to publicly release the results of any revisions to those forward-looking statements which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Contact: John M. McCaffery
Executive Vice President &
Chief Financial Officer
NORWOOD FINANCIAL CORP
272-304-3003
www.waynebank.com 

         
NORWOOD FINANCIAL CORP        
Consolidated Balance Sheets        
(dollars in thousands, except share and per share data)        
 (unaudited)        
    March 31
    2025     2024  
ASSETS        
   Cash and due from banks $ 31,729   $ 19,519  
   Interest-bearing deposits with banks   43,678     92,444  
          Cash and cash equivalents   75,407     111,963  
         
  Securities available for sale   408,742     398,374  
  Loans receivable   1,771,269     1,621,448  
  Less: Allowance for credit losses   20,442     18,020  
     Net loans receivable   1,750,827     1,603,428  
  Regulatory stock, at cost   7,616     6,545  
  Bank premises and equipment, net   20,273     18,057  
  Bank owned life insurance   46,914     45,869  
  Foreclosed real estate owned       97  
  Accrued interest receivable   8,587     8,135  
  Deferred tax assets, net   17,859     21,642  
  Goodwill   29,266     29,266  
  Other intangible assets   136     202  
  Other assets   10,417     16,845  
          TOTAL ASSETS $ 2,376,044   $ 2,260,423  
         
LIABILITIES        
   Deposits:        
     Non-interest bearing demand $ 391,377   $ 383,362  
     Interest-bearing   1,613,071     1,455,636  
          Total deposits   2,004,448     1,838,998  
  Short-term borrowings       60,055  
  Other borrowings   118,590     151,179  
  Accrued interest payable   13,864     11,737  
  Other liabilities   18,435     17,241  
            TOTAL LIABILITIES   2,155,337     2,079,210  
         
STOCKHOLDERS’ EQUITY        
  Preferred Stock, no par value per share, authorized 5,000,000 shares        
  Common Stock, $.10 par value per share,        
         authorized: 20,000,000 shares,        
         issued: 2025: 9,489,398 shares, 2024: 8,310,847 shares   949     831  
  Surplus   126,785     97,893  
  Retained earnings   127,865     137,285  
  Treasury stock, at cost: 2025: 229,979 shares, 2024: 200,690 shares   (6,208 )   (5,397 )
  Accumulated other comprehensive loss   (28,684 )   (49,399 )
           TOTAL STOCKHOLDERS’ EQUITY   220,707     181,213  
         
          TOTAL LIABILITIES AND        
                 STOCKHOLDERS’ EQUITY $ 2,376,044   $ 2,260,423  
         
         
NORWOOD FINANCIAL CORP        
Consolidated Statements of Income        
(dollars in thousands, except per share data)        
  (unaudited)        
    Three Months Ended March 31,
    2025     2024  
INTEREST INCOME        
    Loans receivable, including fees $ 25,988   $ 23,681  
    Securities   3,870     2,526  
    Other   226     731  
         Total Interest income   30,084     26,938  
         
INTEREST EXPENSE        
   Deposits   10,748     10,110  
   Short-term borrowings   458     336  
   Other borrowings   1,021     1,782  
        Total Interest expense   12,227     12,228  
NET INTEREST INCOME   17,857     14,710  
PROVISION FOR (RELEASE OF) CREDIT LOSSES $ 857   $ (624 )
NET INTEREST INCOME AFTER PROVISION FOR (RELEASE OF) CREDIT LOSSES   17,000     15,334  
         
         
OTHER INCOME        
    Service charges and fees   1,513     1,343  
    Income from fiduciary activities   325     238  
    Gains on sales of loans, net   47     6  
    Earnings and proceeds on life insurance policies   286     268  
    Other   180     151  
           Total other income   2,351     2,006  
         
OTHER EXPENSES        
      Salaries and employee benefits   6,472     6,135  
      Occupancy, furniture and equipment   1,378     1,261  
      Data processing and related operations   1,085     1,022  
      Taxes, other than income   192     93  
      Professional fees   659     585  
      FDIC Insurance assessment   406     361  
      Foreclosed real estate   4     21  
      Amortization of intangibles   15     19  
      Other   1,853     2,235  
             Total other expenses   12,064     11,732  
         
INCOME BEFORE TAX EXPENSE   7,287     5,608  
INCOME TAX EXPENSE   1,514     1,175  
NET INCOME $ 5,773   $ 4,433  
         
Basic earnings per share $ 0.63   $ 0.55  
         
Diluted earnings per share $ 0.63   $ 0.55  
             

NORWOOD FINANCIAL CORP                                    
NET INTEREST MARGIN ANALYSIS                                    
(dollars in thousands)                                    
                                     
  For the Quarter Ended
  March 31, 2025 December 31, 2024 March 31, 2024
  Average   Average   Average   Average   Average   Average  
  Balance Interest    Rate   Balance Interest     Rate   Balance Interest     Rate  
  (2) (1) (3)   (2) (1) (3)   (2) (1) (3)  
Assets                                    
Interest-earning assets:                                    
  Interest-bearing deposits with banks $ 20,802   $ 226   4.41   % $ 46,629   $ 574   4.90   % $ 53,930   $ 730   5.44   %
   Securities available for sale:                                    
     Taxable   408,427     3,623   3.60       404,777     2,434   2.39       402,275     2,147   2.15    
     Tax-exempt (1)   44,242     312   2.86       65,628     449   2.72       69,880     481   2.77    
        Total securities available for sale (1)   452,669     3,935   3.53       470,405     2,883   2.44       472,155     2,628   2.24    
     Loans receivable (1) (4) (5)   1,743,572     26,120   6.08       1,690,650     26,246   6.18       1,612,106     23,775   5.93    
        Total interest-earning assets   2,217,043     30,281   5.54       2,207,684     29,703   5.35       2,138,191     27,133   5.10    
Non-interest earning assets:                                    
   Cash and due from banks   28,705             27,283             24,593          
   Allowance for credit losses   (20,154 )           (18,741 )           (19,096 )        
   Other assets   93,131             83,506             73,692          
        Total non-interest earning assets   101,682             92,048             79,189          
Total Assets $ 2,318,725           $ 2,299,732           $ 2,217,380          
Liabilities and Stockholders’ Equity                                    
Interest-bearing liabilities:                                    
   Interest-bearing demand and money market $ 546,884   $ 2,801   2.08     $ 528,330   $ 3,017   2.27     $ 449,825   $ 2,311   2.07    
   Savings   211,905     142   0.27       209,362     162   0.31       235,545     250   0.43    
   Time   793,803     7,805   3.99       764,819     7,805   4.06       725,199     7,549   4.19    
      Total interest-bearing deposits   1,552,592     10,748   2.81       1,502,511     10,984   2.91       1,410,569     10,110   2.88    
Short-term borrowings   44,297     458   4.19       46,267     348   2.99       57,997     336   2.33    
Other borrowings   93,549     1,021   4.43       133,620     1,528   4.55       155,498     1,782   4.61    
   Total interest-bearing liabilities   1,690,438     12,227   2.93       1,682,398     12,860   3.04       1,624,064     12,228   3.03    
Non-interest bearing liabilities:                                    
   Demand deposits   380,544             394,001             386,066          
   Other liabilities   29,549             30,352             25,162          
      Total non-interest bearing liabilities   410,093             424,353             411,228          
   Stockholders’ equity   218,194             192,981             182,088          
Total Liabilities and Stockholders’ Equity $ 2,318,725           $ 2,299,732           $ 2,217,380          
Net interest income/spread (tax equivalent basis)       18,054   2.61   %       16,843   2.31   %       14,905   2.08   %
Tax-equivalent basis adjustment       (197 )           (218 )           (195 )    
Net interest income     $ 17,857           $ 16,625           $ 14,710      
Net interest margin (tax equivalent basis)         3.30   %         3.04   %         2.80   %
                                     
                                     
(1) Interest and yields are presented on a tax-equivalent basis using a marginal tax rate of 21%.                           
(2) Average balances have been calculated based on daily balances.                              
(3) Annualized                                    
(4) Loan balances include non-accrual loans and are net of unearned income.                            
(5) Loan yields include the effect of amortization of deferred fees, net of costs.                            

NORWOOD FINANCIAL CORP        
Financial Highlights (Unaudited)        
(dollars in thousands, except per share data)        
         

For the Three Months Ended March 31
  2025     2024  
         
Net interest income $ 17,857   $ 14,710  
Net income   5,773     4,433  
         
Net interest spread (fully taxable equivalent)   2.61 %   2.08 %
Net interest margin (fully taxable equivalent)   3.30 %   2.80 %
Return on average assets   1.01 %   0.80 %
Return on average equity   10.73 %   9.79 %
Return on average tangible equity   12.40 %   11.68 %
Basic earnings per share $ 0.63   $ 0.55  
Diluted earnings per share $ 0.63   $ 0.55  
         

As of March 31
  2025     2024  
         
Total assets $ 2,376,044   $ 2,260,423  
Total loans receivable   1,771,269     1,621,448  
Allowance for credit losses   20,442     18,020  
Total deposits   2,004,448     1,838,998  
Stockholders’ equity   220,707     181,213  
Trust assets under management   198,761     202,020  
         
Book value per share $ 23.84   $ 22.34  
Tangible book value per share $ 20.66   $ 18.71  
Equity to total assets   9.29 %   8.02 %
Allowance to total loans receivable   1.15 %   1.11 %
Nonperforming loans to total loans   0.45 %   0.23 %
Nonperforming assets to total assets   0.33 %   0.17 %
         

NORWOOD FINANCIAL CORP                    
Consolidated Balance Sheets (unaudited)                    
(dollars in thousands)                    
    March 31   December 31   September 30   June 30   March 31
    2025   2024   2024   2024   2024
ASSETS                    
Cash and due from banks $ 31,729 $ 27,562 $ 47,072 $ 29,903 $ 19,519
Interest-bearing deposits with banks   43,678   44,777   35,808   39,492   92,444
Cash and cash equivalents   75,407   72,339   82,880   69,395   111,963
                     
Securities available for sale   408,742   397,846   396,891   397,578   398,374
Loans receivable   1,771,269   1,713,638   1,675,139   1,641,356   1,621,448
Less: Allowance for credit losses   20,442   19,843   18,699   17,807   18,020
Net loans receivable   1,750,827   1,693,795   1,656,440   1,623,549   1,603,428
Regulatory stock, at cost   7,616   13,366   6,329   6,443   6,545
Bank owned life insurance   46,914   46,657   46,382   46,121   45,869
Bank premises and equipment, net   20,273   19,657   18,503   18,264   18,057
Foreclosed real estate owned           97
Goodwill and other intangibles   29,402   29,418   29,433   29,449   29,468
Other assets   36,863   44,384   42,893   44,517   46,622
TOTAL ASSETS $ 2,376,044 $ 2,317,462 $ 2,279,751 $ 2,235,316 $ 2,260,423
                     
LIABILITIES                    
Deposits:                    
Non-interest bearing demand $ 391,377 $ 381,479 $ 420,967 $ 391,849 $ 383,362
Interest-bearing deposits   1,613,071   1,477,684   1,434,284   1,419,323   1,455,636
Total deposits   2,004,448   1,859,163   1,855,251   1,811,172   1,838,998
Borrowings   118,590   214,862   197,412   210,422   211,234
Other liabilities   32,299   29,929   31,434   31,534   28,978
TOTAL LIABILITIES   2,155,337   2,103,954   2,084,097   2,053,128   2,079,210
                     
STOCKHOLDERS’ EQUITY   220,707   213,508   195,654   182,188   181,213
                     
TOTAL LIABILITIES AND                    
STOCKHOLDERS’ EQUITY $ 2,376,044 $ 2,317,462 $ 2,279,751 $ 2,235,316 $ 2,260,423
                     

NORWOOD FINANCIAL CORP                    
Consolidated Statements of Income (unaudited)                    
(dollars in thousands, except per share data)                    
    March 31   December 31   September 30   June 30   March 31
Three months ended   2025    2024    2024    2024    2024 
INTEREST INCOME                    
Loans receivable, including fees $ 25,988   $ 26,122   $ 25,464   $ 24,121   $ 23,681  
Securities   3,870     2,789     2,526     2,584     2,526  
Other   226     574     497     966     731  
Total interest income   30,084     29,485     28,487     27,671     26,938  
                     
INTEREST EXPENSE                    
Deposits   10,748     10,984     10,553     10,687     10,110  
Borrowings   1,479     1,876     2,003     2,059     2,118  
Total interest expense   12,227     12,860     12,556     12,746     12,228  
NET INTEREST INCOME   17,857     16,625     15,931     14,925     14,710  
PROVISION FOR (RELEASE OF) CREDIT LOSSES   857     1,604     1,345     347     (624 )
NET INTEREST INCOME AFTER (RELEASE OF) PROVISION                    
FOR CREDIT LOSSES   17,000     15,021     14,586     14,578     15,334  
                     
OTHER INCOME                    
Service charges and fees   1,513     1,595     1,517     1,504     1,343  
Income from fiduciary activities   325     224     256     225     238  
Net realized (losses) gains on sales of securities       (19,962 )            
Gains on sales of loans, net   47     50     103     36     6  
Gains on sales of foreclosed real estate owned               32      
Earnings and proceeds on life insurance policies   286     275     261     253     268  
Other   180     159     158     157     151  
Total other income   2,351     (17,659 )   2,295     2,207     2,006  
                     
OTHER EXPENSES                    
Salaries and employee benefits   6,472     6,690     6,239     5,954     6,135  
Occupancy, furniture and equipment, net   1,378     1,291     1,269     1,229     1,261  
Foreclosed real estate   4     9     9     15     21  
FDIC insurance assessment   406     335     339     309     361  
Other   3,804     5,094     4,175     3,937     3,954  
Total other expenses   12,064     13,419     12,031     11,444     11,732  
                     
INCOME BEFORE TAX (BENEFIT) EXPENSE   7,287     (16,057 )   4,850     5,341     5,608  
INCOME TAX (BENEFIT) EXPENSE   1,514     (3,406 )   1,006     1,128     1,175  
NET (LOSS) INCOME $ 5,773   $ (12,651 ) $ 3,844   $ 4,213   $ 4,433  
                     
Basic (loss) earnings per share $ 0.63   $ (1.54 ) $ 0.48   $ 0.52   $ 0.55  
                     
Diluted (loss) earnings per share $ 0.63   $ (1.54 ) $ 0.48   $ 0.52   $ 0.55  
                     
Book Value per share $ 23.84   $ 23.02   $ 24.18   $ 22.52   $ 22.34  
Tangible Book Value per share   20.66     19.85     20.54     18.88     18.71  
                     
Return on average assets (annualized)   1.01 %   -2.19 %   0.68 %   0.75 %   0.80 %
Return on average equity (annualized)   10.73 %   -26.08 %   8.09 %   9.41 %   9.79 %
Return on average tangible equity (annualized)   12.40 %   -30.77 %   9.58 %   11.26 %   11.68 %
                     
Net interest spread (fte)   2.61 %   2.31 %   2.23 %   2.06 %   2.08 %
Net interest margin (fte)   3.30 %   3.04 %   2.99 %   2.80 %   2.80 %
                     
Allowance for credit losses to total loans   1.15 %   1.16 %   1.12 %   1.08 %   1.11 %
Net charge-offs to average loans (annualized)   0.07 %   0.12 %   0.08 %   0.13 %   0.08 %
Nonperforming loans to total loans   0.45 %   0.46 %   0.47 %   0.47 %   0.23 %
Nonperforming assets to total assets   0.33 %   0.34 %   0.35 %   0.34 %   0.17 %



Dr. Charles Howe of the Mayo Clinic’s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt’s Subsidiary Adimune™

Dr. Charles Howe of the Mayo Clinic’s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt’s Subsidiary Adimune™

MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform accelerating promising health innovations, announced that Dr. Charles Howe, Chair of the Division of Experimental Neurology and Director of Research at the Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology, will join the Aditxt Weekly Update on May 2, 2025, to discuss key findings from the newly announced preclinical study evaluating ADI-100™, the lead therapeutic candidate developed by its wholly owned subsidiary, Adimune™, Inc. (“Adimune”).

Featured participants will include Dr. Shahrokh Shabahang, Chief Innovation Officer of Aditxt, Inc., and Dr. Friedrich Kapp, Co-Chief Executive Officer of Adimune™, Inc.

Event Details:

Title: Aditxt Weekly Update

Date: Friday, May 2, 2025

Time: 11:30 a.m. ET

Location: Virtual (Zoom)

Registration:Click here to register

About Adimune

Adimune is a pre-clinical stage biopharmaceutical company pioneering a new class of immune modulation therapies designed to restore natural immune tolerance. Adimune’s mission is to advance immune health by providing targeted, long-term solutions that minimize reliance on chronic immunosuppression—transforming treatment for autoimmune diseases and organ transplantation.

One of Adimune’s innovations is ADI-100™, a first-in-class Apoptotic DNA Immunotherapy™ that mimics the body’s natural mechanisms for maintaining immune tolerance. This proprietary platform uses nucleic acid technology to deliver two coordinated signals: one encoding BAX, a protein that promotes targeted apoptosis, and another encoding a modified disease-specific antigen to re-establish immune tolerance.

To learn more and view the corporate presentation, please visit adimune.com.

About ADI-100

ADI-100™ is an investigational antigen-specific gene therapy that consists of two DNA molecules designed to restore immune tolerance in autoimmune diseases or to induce tolerance to transplanted organs. This approach is designed to retrain the immune system to recognize antigens as “self” without relying on immunosuppression, offering the possibility of significant safety and efficacy benefits.

The therapy consists of a pro-apoptotic DNA molecule (BAX), which has been shown in preclinical models to induce localized apoptotic cell death combined with a modified form of GAD to retrain the immune system to become tolerant to the antigen.

ADI-100™ is designed to work through precision immune reprogramming, downregulating pro-inflammatory cytokines while upregulating anti-inflammatory cytokines in an antigen-specific manner. It tolerizes to GAD, which is a target of autoimmunity, directly or indirectly involved in Type 1 Diabetes, Psoriasis, and certain CNS autoimmune disorders. In the mouse model for type 1 diabetes, ADI-100™ demonstrated a reduction in the number of aggressive T cells directed against insulin, which is another antigen in the pancreas that is a target of autoimmune attack. This bystander effect is an important factor to counteract a phenomenon often observed where autoimmunity spreads to other regions of a protein or to other proteins in a cell. Another potential benefit of downregulating anti-GAD antibodies by ADI-100™ is restoration of GABA levels, further enhancing the tolerization process.

About Aditxt, Inc.

Aditxt, Inc.® is a social innovation platform accelerating promising health innovations. Aditxt’s ecosystem of research institutions, industry partners, and shareholders collaboratively drives their mission to “Make Promising Innovations Possible Together.” The innovation platform is the cornerstone of Aditxt’s strategy, where multiple disciplines drive disruptive growth and address significant societal challenges. Aditxt operates a unique model that democratizes innovation, ensures every stakeholder’s voice is heard and valued, and empowers collective progress.

Aditxt currently operates two programs focused on immune health and precision health. The Company plans to introduce two additional programs dedicated to public health and women’s health. For these, Aditxt has entered into an Arrangement Agreement with Appili Therapeutics, Inc. (“Appili”) (TSX: APLI; OTCPink: APLIF), which focuses on infectious diseases, and a Merger Agreement with Evofem Biosciences, Inc. (“Evofem”) (OTCQB: EVFM). Each program will be designed to function autonomously while collectively advancing Aditxt’s mission of discovering, developing, and deploying innovative health solutions to tackle some of the most urgent health challenges. The closing of each of the transactions with Appili and Evofem is subject to several conditions, including but not limited to approval of the transactions by the respective target shareholders and Aditxt raising sufficient capital to fund its obligations at closing. These obligations include cash payments of approximately $17 million for Appili and $17 million for Evofem, which includes approximately $15.2 million required to satisfy Evofem’s senior secured noteholder; should Aditxt fail to secure these funds, Evofem’s senior secured noteholder is expected to seek to prevent the closing of the merger with Evofem. No assurance can be provided that all of the conditions to closing will be obtained or satisfied or that either of the transactions will ultimately close.

For more information, www.aditxt.com.

Follow us on:

LinkedIn: https://www.linkedin.com/company/aditxt

Facebook: https://www.facebook.com/aditxtplatform/

Forward-Looking Statements

Certain statements in this press release constitute “forward-looking statements” within the meaning of federal securities laws. Forward-looking statements include statements regarding the Company’s intentions, beliefs, projections, outlook, analyses, or current expectations concerning, among other things, the Company’s ongoing and planned product and business development; the Company’s ability to finance and execute its strategic M&A initiatives; the Company’s ability to obtain the necessary funding and partner to commence clinical trials; the Company’s intellectual property position; the Company’s ability to develop commercial functions; expectations regarding product launch and revenue; the Company’s results of operations, cash needs, spending, financial condition, liquidity, prospects, growth, and strategies; the Company’s ability to raise additional capital; expected usage of the Company’s ELOC and ATM facilities; the industry in which the Company operates; and the trends that may affect the industry or the Company. Forward-looking statements are not guarantees of future performance, and actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, as well as market and other conditions and those risks more fully discussed in the section titled “Risk Factors” in Aditxt’s most recent Annual Report on Form 10-K, as well as discussions of potential risks, uncertainties, and other important factors in the Company’s other filings with the Securities and Exchange Commission. All such statements speak only as of the date made, and the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Aditxt, Inc.

Corporate Communications

Jeff Ramson, PCG Advisory, Inc.

T: 646-863-6893

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Science Neurology Biotechnology Research Pharmaceutical Health Genetics Clinical Trials

MEDIA: